Retatrutide

"Significant Weight Reduction: Clinical trials indicate that participants on high-dose retatrutide lost an average of 17.5% of their body weight at 24 weeks, with reductions reaching over 24% at 48 weeks.

Triple-Hormone Mechanism: Unlike semaglutide (GLP-1) or tirzepatide (GLP-1/GIP), retatrutide adds glucagon receptor agonism, which increases energy expenditure and helps burn more fat.

Improved Metabolic Health & Diabetes Management: It improves glycemic control, reduces HbA1c levels, and boosts insulin sensitivity.

Cardiovascular and Liver Benefits: Studies suggest reductions in blood pressure, improvement in cholesterol levels, and a decrease in liver fat (beneficial for MASLD/NAFLD).

Appetite Suppression: The peptide reduces hunger and cravings, making it easier to maintain a lower calorie intake.

Muscle-Sparing Potential: Evidence suggests that despite rapid weight loss, the compound may help preserve lean muscle mass. 

Side Effects and Considerations"